US Broker Ratings

Alcon Inc. (ALC) Stock Analysis: Eyeing a 20.51% Upside with Strong Buy Ratings

For investors with an eye on the healthcare sector, Alcon Inc. (NYSE: ALC) presents a compelling opportunity. As a leading player in the medical instruments and supplies industry, Alcon focuses..

Qiagen N.V. (QGEN) Stock Analysis: Exploring an 8.52% Potential Upside in the Healthcare Sector

Qiagen N.V. (NYSE: QGEN) stands as a prominent player in the diagnostics and research industry, offering a comprehensive suite of solutions that bridge biological samples to actionable molecular insights. Headquartered..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Strong Buy Ratings and 27% Potential Upside

Neurocrine Biosciences, Inc. (NBIX) stands out in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a market capitalization of $12.41 billion, this San Diego-based company..

HCA Healthcare, Inc. (HCA) Stock Analysis: Navigating a Robust Market Cap with Impressive ROE

HCA Healthcare, Inc. (NYSE: HCA) stands out in the healthcare sector not only for its substantial market capitalization of $92.46 billion but also for its impressive operational metrics that could..

Teleflex Incorporated (TFX) Stock Analysis: Potential 26.97% Upside in the Healthcare Sector

Teleflex Incorporated (NYSE: TFX) stands as a notable player in the healthcare sector, specializing in the design and supply of single-use medical devices. With a market capitalization of $5.43 billion,..

Henry Schein, Inc. (HSIC) Stock Analysis: Exploring an 8.5% Upside in the Healthcare Sector

Investors eyeing opportunities in the healthcare sector should consider Henry Schein, Inc. (NASDAQ: HSIC), a key player in medical distribution with a market capitalization of $8.8 billion. Based in Melville,..

ADMA Biologics Inc (ADMA) Stock Analysis: Potential 43% Upside Amid Robust Revenue Growth

ADMA Biologics Inc (NASDAQ: ADMA) is capturing the attention of investors with its promising growth trajectory in the biotechnology sector. As a key player in the healthcare industry, ADMA specializes..

Option Care Health, Inc. (OPCH) Stock Analysis: A 20.86% Upside Awaits with Strong Buy Ratings

Option Care Health, Inc. (NASDAQ: OPCH), a prominent player in the healthcare sector, specifically within the medical care facilities industry, is capturing investor attention with its robust growth prospects and..

Incyte Corporation (INCY) Stock Analysis: A Biotech Powerhouse with a 7.44% Upside Potential

Incyte Corporation (NASDAQ: INCY) stands as a noteworthy player in the biotechnology sector, boasting a market capitalization of $13.31 billion. This Delaware-based biopharmaceutical company is renowned for its innovation in..

Bruker Corporation (BRKR) Investor Outlook: A 46% Upside Potential Amid Healthcare Innovation

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector and a specialist in medical devices, is drawing considerable attention from investors with a compelling potential upside of 46.15%...

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Exploring a 23.50% Upside Potential in Biotech Innovation

Halozyme Therapeutics, Inc. (NASDAQ: HALO) is making waves in the biotechnology sector with its innovative approach to drug delivery systems. Headquartered in San Diego, California, this biopharmaceutical company is leveraging..

Legend Biotech Corporation (LEGN) Stock Analysis: Unveiling a 118% Potential Upside in Oncology Biotech

Legend Biotech Corporation (NASDAQ: LEGN) is capturing investor attention with its impressive growth trajectory in the biotechnology sector, particularly in developing innovative cell therapies for oncology. The U.S.-based company is..

Fresenius Medical Care AG (FMS): Investor Outlook on a German Healthcare Giant with a Stable Dividend Yield

Fresenius Medical Care AG (FMS) stands as a formidable player in the healthcare sector, particularly within the medical care facilities industry. Based in Germany, this multinational corporation is a global..

Viatris Inc. (VTRS) Stock Analysis: Navigating Opportunities Amidst A Potential 30% Upside

Investors are taking a closer look at Viatris Inc. (VTRS), a prominent player in the healthcare sector with a specialization in both specialty and generic drug manufacturing. With a market..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: A 32.6% Upside Potential Beckons Investors

Teva Pharmaceutical Industries (TEVA), a stalwart in the healthcare sector, continues to hold a significant position in the global pharmaceutical industry, specializing in drug manufacturing—particularly in the specialty and generic..

ResMed Inc. (RMD) Investor Outlook: Evaluating a 4.87% Potential Upside in Healthcare Innovations

ResMed Inc. (RMD), a prominent player in the healthcare sector specializing in medical instruments and supplies, is capturing investor attention with its innovative approach to respiratory care and software solutions...

Solventum Corporation (SOLV): Healthcare Innovator with a 9.79% Potential Upside

Solventum Corporation (SOLV), a prominent player in the healthcare sector, stands out with a market capitalization of $12.95 billion. As a company entrenched in the Medical Instruments & Supplies industry,..

Roivant Sciences Ltd. (ROIV): Investor Outlook with a Promising 49% Potential Upside

Roivant Sciences Ltd. (NASDAQ: ROIV), a prominent player in the biotechnology sector, is capturing investor attention with its robust pipeline and significant potential upside. Based in London, the company is..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: A 22% Upside Potential Awaits Investors

GE HealthCare Technologies Inc. (NYSE: GEHC), a leading player in the healthcare sector, has garnered significant interest from investors, thanks to its robust growth potential and strategic positioning in the..

DaVita Inc. (DVA) Stock Analysis: Investor Outlook Highlights 18% Potential Upside

DaVita Inc. (NYSE: DVA), a prominent player in the healthcare sector, specifically within the medical care facilities industry, is catching the attention of investors with its steady presence in the..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds